About Scott Edil Pharmacia Limited
Data last updated:
Scott Edil Pharmacia Limited is a public limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 January 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2003PLC025699. Its GSTIN is 04AAHCS1643K1ZD (Chandigarh). The company holds 11 GST registrations, of which 7 are active.
The company has an authorised share capital of ₹13 Cr and a paid-up capital of ₹12.77 Cr. It is led by directors including Vaishali Aggarwal (Managing Director) and Sanjeev Kumar (Managing Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 28/6 Industrial Area Phase – 2, Chandigarh, India – 160002.
As per the financials filed for FY 2025, the company reported a revenue of ₹847.96 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹54.66 Cr (net margin 6.4%) and EBITDA of ₹104.2 Cr (EBITDA margin 12.3%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 12% over five years.
The company has about 803 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Scott Edil Pharmacia. As per MCA filings, the company has open charges of ₹351.44 Cr and satisfied charges of ₹115.73 Cr on record. Court records list 136 cases involving the company, including 55 filed by the company and 81 filed against it; 27 cases are pending. The company has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹17.22 Cr; the latest was in February 2018. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Lee Pharma Limited with revenue of ₹928.7 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website scott-edil.com.
Company details
CIN history
Scott Edil Pharmacia has one previous CIN (Corporate Identification Number): L24232CH2003PLC025699. The current CIN is U24232CH2003PLC025699, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232CH2003PLC025699 | Current |
| L24232CH2003PLC025699 | Previous |
Contact details
Scott Edil Pharmacia Limited's registered office is in Chandigarh, Chandigarh. Its website is scott-edil.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 28/6 Industrial Area Phase – 2, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Scott Edil Pharmacia Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Scott Edil Pharmacia operates one associated brand: Scott Edil Pharmacia. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| An ISO and WHO GMP-certified manufacturer with over 400 pharmaceutical products. | scott-edil.com |
Business activity
The main business activity of Scott Edil Pharmacia is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Scott Edil Pharmacia Limited, buy the company report.
Financials of Scott Edil Pharmacia Limited
FY 2024 filings availableScott Edil Pharmacia Limited reported revenue of ₹847.96 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 7% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹104.2 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹54.66 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.3% | ||||
| Net Profit Margin | 6.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Scott Edil Pharmacia Limited, buy the company report.
Board of directors of Scott Edil Pharmacia Limited
Scott Edil Pharmacia has 5 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Munish Kumar | Director | 01 Aug 2017 | 9 Years 2 Months | Current |
| Pushkin Sharma | Director | 18 Oct 2017 | 9 Years 0 Months | Current |
| Vaishali Aggarwal | Managing Director | 06 Jan 2003 | 23 Years 9 Months | Current |
| Sanjeev Kumar | Managing Director | 06 Jan 2003 | 23 Years 9 Months | Current |
| Balram Krishan | Director | 06 Jan 2003 | 23 Years 9 Months | Current |
Peer comparison
Scott Edil Pharmacia Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lee Pharma Limited | ₹928.7 Cr (FY 2025) | 2.0% | Hyderabad, Telangana, India | |||
| Punjab Chemicals and Crop Protection Limited | ₹901.95 Cr (FY 2025) | -4.0% | Derabassi, Punjab, India | |||
| Rubicon Research Limited | ₹872.39 Cr (FY 2024) | 108.0% | Thane, Maharashtra, India | |||
| Fresenius Kabi Oncology Limited | ₹848.26 Cr (FY 2025) | 4.0% | New Delhi, Delhi, India | |||
| Scott Edil Pharmacia Limitedthis company | ₹847.96 Cr (FY 2025) | ₹54.66 Cr | 6.4% | 7.0% | 803 | Chandigarh, India |
| Bliss GVS Pharma Limited | ₹846.22 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Apex Laboratories Private Limited | ₹834.88 Cr (FY 2025) | 7.0% | Chennai, Tamil Nadu, India | |||
| Gufic Biosciences Limited | ₹823.43 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Scott Edil Pharmacia Limited, buy the company report.
Auditor
Scott Edil Pharmacia Limited is audited by RAH & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAH & Co | FY 2023 | 027519N |
Shareholding
The shareholding of Scott Edil Pharmacia Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Scott Edil Pharmacia Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Sep 2025 | 101168810 | Uco Bank | ₹65 Lakh | Open | |
| 04 Jul 2025 | 101122955 | Uco Bank | ₹11.4 Cr | Open | |
| 19 Jun 2025 | 101121798 | Others | ₹23.85 Lakh | Open | |
| 06 May 2025 | 101100464 | Others | ₹98.6 Lakh | Open | |
| 03 Aug 2024 | 100958720 | Uco Bank | ₹3 Cr | Open |
To see the full charge records of Scott Edil Pharmacia Limited, buy the company report.
Total charge records: 30 View all charges
Deals & funding
Scott Edil Pharmacia Limited has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹17.22 Cr; the latest was in February 2018.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2018 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 4 individuals |
| Mar 2017 | Funding round | ₹15.66 Cr | Investors: 4 individuals |
| Jul 2013 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Jul 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Mar 2009 | Funding round | ₹27 Lakh | Investors: 2 individuals |
To see the full deal history of Scott Edil Pharmacia Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Scott Edil Pharmacia Limited has 136 court cases on record: 55 filed by Scott Edil Pharmacia, 81 filed against it. 27 cases are pending and 109 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 68 | 38 | 12 |
| District courts | 67 | 42 | 15 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 136)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Glaxosmithkline Pharmaceuticals Limited | Pending |
| High Court | Court case (COMIP) | Filed against the company by Sanofi India Limited and 2 others | Pending |
| High Court, ANDHRAPRADESH | Court case (CRLP) | Filed against the company by M/S Pro Laboratories Pvt Ltd | Pending |
| High Court of Madhya Pradesh | Writ petition | Filed by the company against Madhya Pradesh Public Health Services Corporation Ltd THR. Its Managing Director and 2 others | Pending |
| High Court | Court case (CWJC) | Filed by the company against The Bihar Medical Services and Infrastructure Corporation Ltd. Through Its Managing Director 5Th Flo and 4 others | Pending |
To see the full case history of Scott Edil Pharmacia Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Scott Edil Pharmacia Limited was last rated by Care on 02 Aug 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 02 Aug 2021 |
To see the full credit ratings and regulatory alerts of Scott Edil Pharmacia Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Scott Edil Pharmacia Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Scott Edil Pharmacia has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Scott-Edil Advance Research Laboratories & Education Limited | U24232CH2009PLC031649 |
To see the full group structure of Scott Edil Pharmacia Limited, buy the company report.
Employees & EPFO
Scott Edil Pharmacia Limited has a workforce of 803 employees on its EPFO records as of Mar 26, 2025, across 2 active EPFO establishments.
GST
Scott Edil Pharmacia has 11 GST registrations: 7 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAHCS1643K1ZD | Chandigarh | Active | 01 Jul 2017 |
| 02AAHCS1643K1ZH | Himachal Pradesh | Active | 01 Jul 2017 |
| 27AAHCS1643K1Z5 | Maharashtra | Active | 03 Jul 2019 |
| 06AAHCS1643K1Z9 | Haryana | Active | 27 Jun 2020 |
To see the full GST registrations and return filing status of Scott Edil Pharmacia Limited, buy the company report.
Recent activity
Scott Edil Pharmacia Limited has 17 board changes on record since 2003: 5 appointments and 12 cessations. The latest: Akhilesh Kumar ceased to be Cfo(Kmp) on 20 Aug 2020.
59 earlier events are in the company report.
Frequently asked questions
Scott Edil Pharmacia is an active public limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 January 2003 (23+ years old) and is registered under CIN U24232CH2003PLC025699.
Scott Edil Pharmacia has 5 current directors:
- Vaishali Aggarwal - Managing Director
- Sanjeev Kumar - Managing Director
- Munish Kumar - Director
- Pushkin Sharma - Director
- Balram Krishan - Director
The latest financial statements of Scott Edil Pharmacia on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Scott Edil Pharmacia is 04AAHCS1643K1ZD, registered in Chandigarh. The company has 11 GST registrations in all, of which 7 are active and 4 are cancelled or inactive. Other active GSTINs include 02AAHCS1643K1ZH (Himachal Pradesh), 27AAHCS1643K1Z5 (Maharashtra), 06AAHCS1643K1Z9 (Haryana).
The CIN (Corporate Identification Number) of Scott Edil Pharmacia is U24232CH2003PLC025699. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Scott Edil Pharmacia has 136 court cases on record: 55 filed by the company and 81 filed against it. 27 are pending. Most are in the high courts.
Scott Edil Pharmacia was incorporated on 06 January 2003, making it 23+ years old. It is registered with the Registrar of Companies, Chandigarh.
Scott Edil Pharmacia has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹17.22 Cr; the latest was in February 2018.
The peers of Scott Edil Pharmacia by revenue are Lee Pharma Limited, Punjab Chemicals and Crop Protection Limited, Rubicon Research Limited, Fresenius Kabi Oncology Limited, Bliss GVS Pharma Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Akhilesh Kumar ceased to be Cfo(Kmp) on 20 Aug 2020. Raghav Mittal ceased to be Additional Director on 30 Aug 2019. Vijay Kumar Joshi ceased to be Director on 30 Aug 2019. Scott Edil Pharmacia has 17 board changes on record in total.
Scott Edil Pharmacia can be reached through the website scott-edil.com. Its registered office is in Chandigarh, India.